Drug search by name

Zofran (Ondansetron Oral Solution) and QT interval prolongation

Result of checking the interaction of drug Zofran (Ondansetron Oral Solution) and disease QT interval prolongation for safety when used together.

Check result:

Zofran (Ondansetron Oral Solution) <> QT interval prolongation

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

ECG changes including QT interval prolongation have been observed in patients receiving ondansetron. Additionally, there have been some postmarketing reports of Torsade de Pointes cases. The use of ondansetron should be avoided in patients with congenital long QT syndrome. ECG monitoring is recommended in patients with electrolyte abnormalities such as hypokalemia or hypomagnesemia, patients with congestive heart failure, bradyarrhythmias, or patients taking other medicines that could lead to QT prolongation.

Zofran (Ondansetron Oral Solution)

Generic Name: ondansetron

Brand Name: Zofran, Zofran ODT, Zuplenz

Synonyms: Zofran

What is Zofran (Ondansetron Oral Solution)?